BioWitt ApS: Financial statements 2023
CVR: 32829554
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
BioWitt ApS (CVR 32829554) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -1,749 and a net result of DKK 23,108 compared with DKK -32,837 the year before. Equity in the 2023 report amounted to DKK 490,457. The solvency ratio was 91.7%.
- Gross Profit
- DKK -1,749
- Profit/Loss
- DKK 23,108
- Equity
- DKK 490,457
- Total Assets
- DKK 535,052
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -2 t. | 23 t. | 490 t. | - |
| 2022 | - | -2 t. | -33 t. | 467 t. | - |
| 2021 | - | -4 t. | 34 t. | 614 t. | - |
| 2020 | - | -3 t. | 14 t. | 580 t. | - |
| 2019 | - | -4 t. | 64 t. | 567 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
BioWitt ApS has published its annual report for 2022. Gross profit came to DKK -2,029, and the net result was DKK -32,837.
About BioWitt ApS
BioWitt ApS is a Danish company of the type Anpartsselskab based in Ribe, founded in 2010. The company is registered under the industry Anden teknisk rådgivning. The company was previously named PETER WITT HOLDING ApS. The management consists of Peter Witt. The company is owned by Peter Witt. The company has 2 employees (2025). In 2025, the company reported a gross profit of DKK 26,445 and a net result of DKK 16,061 compared with DKK 17,610 the year before. Equity in the 2025 report amounted to DKK 294,128.